- RecruitingPHASE2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
This study looks at new treatments for pancreatic cancer after surgery. It compares a new combination of drugs (Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX) with a standard treatment (mFOLFIRINOX alone) to see which works best and is safest for patients with no remaining cancer after their operation.
For: Adenocarcinoma, Pancreatic DuctalUnited States · Belgium · Canada - RecruitingPHASE2
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
This study looks at giving chemotherapy before surgery for a type of pancreatic cancer that is tricky to remove. Doctors want to see if this approach is practical and safe, and if it helps patients better prepare for surgery.
For: Pancreatic AdenocarcinomaCanada - RecruitingPHASE1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
This study is looking at a new treatment called INCB161734 for advanced cancers with a specific genetic change (KRAS G12D mutation). Researchers want to see if it's safe and how well it works, either alone or with other cancer drugs.
For: Solid TumorsUnited States · Australia · Belgium